Evidence map›Paper›PMID 25246591›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Basis for substrate recognition and distinction by matrix metalloproteinases.

Boris I Ratnikov, Piotr Cieplak, Kosi Gramatikoff, James Pierce, Alexey Eroshkin, Yoshinobu Igarashi, Marat Kazanov, Qing Sun, Adam Godzik, Andrei Osterman and 3 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Computational design of metalloproteases.bioRxiv : the preprint server for biology · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. In situ formed depot of elastin-like polypeptide-hirudin fusion protein for long-acting antithrombotic therapy.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Boris I RatnikovThe Cancer Center and.
Piotr CieplakThe Cancer Center and.
Kosi GramatikoffThe Cancer Center and.
James PierceThe Cancer Center and.
Alexey EroshkinThe Cancer Center and.
Yoshinobu IgarashiThe Cancer Center and.
Marat KazanovResearch and Training Center on Bioinformatics, Institute for Information Transmission Problems, Russian Academy of Sciences, Moscow 127994, Russia.
Qing SunThe Cancer Center and.
Adam GodzikThe Cancer Center and The Inflammatory and Infectious Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037; and.
Andrei OstermanThe Cancer Center and The Inflammatory and Infectious Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037; and.
Boguslaw StecThe Cancer Center and.
Alex StronginThe Cancer Center and The Inflammatory and Infectious Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037; and.
Jeffrey W SmithThe Cancer Center and jsmith@sanfordburnham.org.

Funding

Proteolysis of Myelin as a Source of Neuropathic PainR01DE022757 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHUBAYEV, VERONICA · 2012 to 2022
$7.3M
METALLOPROTEINASES IN TUMOR NEOVASCULARIZATIONR01CA083017 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI STRONGIN, ALEX Y · 1999 to 2014
$3.8M
Biochemistry of MT1-MMP activation in malignancyR01CA157328 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI STRONGIN, ALEX Y · 2011 to 2015
$1.9M
Proteolysis in silico: statistics, structural chemistry, and biologyR01GM098835 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI CIEPLAK, PIOTR · 2011 to 2014
$1.5M
NCI NIH HHS CA157328NCI NIH HHS CA83017NCI NIH HHS R01 CA083017NCI NIH HHS R01 CA157328NCRR NIH HHS RR080243NIDCR NIH HHS DE022757NIDCR NIH HHS R01 DE022757NIGMS NIH HHS GM098835NIGMS NIH HHS R01 GM098835
6 · The paper itself

Abstract

Genomic sequencing and structural genomics produced a vast amount of sequence and structural data, creating an opportunity for structure-function analysis in silico [Radivojac P, et al. (2013) Nat Methods 10(3):221-227]. Unfortunately, only a few large experimental datasets exist to serve as benchmarks for function-related predictions. Furthermore, currently there are no reliable means to predict the extent of functional similarity among proteins. Here, we quantify structure-function relationships among three phylogenetic branches of the matrix metalloproteinase (MMP) family by comparing their cleavage efficiencies toward an extended set of phage peptide substrates that were selected from ∼ 64 million peptide sequences (i.e., a large unbiased representation of substrate space). The observed second-order rate constants [k(obs)] across the substrate space provide a distance measure of functional similarity among the MMPs. These functional distances directly correlate with MMP phylogenetic distance. There is also a remarkable and near-perfect correlation between the MMP substrate preference and sequence identity of 50-57 discontinuous residues surrounding the catalytic groove. We conclude that these residues represent the specificity-determining positions (SDPs) that allowed for the expansion of MMP proteolytic function during evolution. A transmutation of only a few selected SDPs proximal to the bound substrate peptide, and contributing the most to selectivity among the MMPs, is sufficient to enact a global change in the substrate preference of one MMP to that of another, indicating the potential for the rational and focused redesign of cleavage specificity in MMPs.

Indexed as

Catalytic DomainAlgorithmsAmino Acid SequenceBinding SitesBiocatalysisHumansKineticsMatrix MetalloproteinasesModels, MolecularMolecular Sequence DataMutationPeptidesPhylogenyProteolysisSequence Homology, Amino AcidSubstrate SpecificityMatrix MetalloproteinasesPeptidesMMPsproteasespecificity-determining positions

Identifiers

PMID25246591
PMCPMC4210027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.